000			01641 a2200469 4500
005			20250511205509.0
264		0	_c19921016
008			199210s 0 0 eng d
022			_a0006-4971
040			_aNLM _beng _cNLM
100	1		_aDillman, R O
245	0	0	_aA comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B. _h[electronic resource]
260			_bBlood _cNov 1991
300			_a2520-6 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAcute Disease
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aCytarabine _xadministration & dosage
650	0	4	_aDaunorubicin _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aLeukemia, Myeloid _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aRemission Induction
650	0	4	_aThioguanine _xadministration & dosage
650	0	4	_aTime Factors
650	0	4	_aVincristine _xadministration & dosage
700	1		_aDavis, R B
700	1		_aGreen, M R
700	1		_aWeiss, R B
700	1		_aGottlieb, A J
700	1		_aCaplan, S
700	1		_aKopel, S
700	1		_aPreisler, H
700	1		_aMcIntyre, O R
700	1		_aSchiffer, C
773	0		_tBlood _gvol. 78 _gno. 10 _gp. 2520-6
999			_c1830456 _d1830456